IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF TEXAS SHERMAN DIVISION AMERISOURCEBERGEN SPECIALTY GROUP,

INC., Plaintiff, vs. FFF ENTERPRISES, INC., Defendant.

CASE NO. _______________

JURY TRIAL DEMANDED

ORIGINAL COMPLAINT FOR PATENT INFRINGEMENT This is an action for patent infringement by AmerisourceBergen Specialty Group, Inc. against FFF Enterprises, Inc. I. PARTIES 1. Plaintiff AmerisourceBergen Specialty Group, Inc. (ABSG) is a Delaware

corporation with its principal place of business in Frisco, Texas. 2. Defendant FFF Enterprises, Inc. (FFF Enterprises) is a California corporation

with its principal place of business in Temecula, California. FFF Enterprises has appointed Patrick Maurice Schmidt, 41093 County Center Drive, Temecula, California, 92591, as its agent for service of process. II. JURISDICTION AND VENUE 3. This action arises under the patent laws of the United States, Title 35 of the United

States Code. This Court has subject matter jurisdiction pursuant to 28 U.S.C. 1331 and 1338(a).

ORIGINAL COMPLAINT FOR PATENT INFRINGEMENT

PAGE 1

4.

Venue is proper in this District under 28 U.S.C. 1391(c) and 1400(b). Upon

information and belief, Defendant has transacted business in this District. Defendant has committed and/or induced acts of patent infringement in this District. 5. This Court has personal jurisdiction over Defendant because the infringing systems or

networks, as described below, have been and continue to be directed to or used by consumers in the State of Texas and the Eastern District of Texas. Defendant has committed acts of infringement in violation of 35 U.S.C. 271 and directly or indirectly placed these infringing methods, systems and/or software into the stream of commerce with the knowledge or understanding that such methods, systems and/or software are used in this State and this District. 6. Upon information and belief, Defendant regularly does business and/or solicits

business in Texas and in this District. Upon information and belief, Defendant also offers products for sale using its website, including www.myfluvaccine.com, to customers throughout the United States, including in Texas and in this District. 7. ABSG has its principal place of business in this District. Defendants acts cause

injury to ABSG within the District. III. FACTUAL BACKGROUND 8. On October 9, 2012, the United States Patent & Trademark Office (USPTO)

issued United States Patent No. 8,285,607 (the 607 Patent) entitled System and Method for Pharmaceutical Management and Tracking. ABSG is the current assignee of the 607 Patent. A true and correct copy of the 607 Patent is attached as Exhibit A. 9. The 607 Patent is valid, enforceable, and has not expired. IV. COUNT ONE: INFRINGEMENT OF U.S. PATENT NO. 8,285,607 10. ABSG repeats and re-alleges each and every allegation contained in paragraphs 1

through 9 above as though fully stated herein.

ORIGINAL COMPLAINT FOR PATENT INFRINGEMENT PAGE 2

11.

Defendant has been and is now directly infringing, and indirectly infringing by way

of inducing infringement of, at least claim 1 of the 607 Patent in the State of Texas, in this Judicial District, and elsewhere in the United States by, among other things, making, using, offering to sell, selling, and/or importing systems, covered by one or more claims of the 607 Patent within the United States. By way of example, Defendant exhibited the accused product at the American Society of Health-System Pharmacists meeting in Orlando, Florida in December 2013. 12. Systems made, used, offered for sale, or sold by Defendant that infringe at least

claim 1 of the 607 Patent include, but are not limited to, Defendants products or services associated with Defendants VERIFIED Cabinet and the VERIFIED Inventory Program. Nonlimiting example advertisements of Defendants VERIFIED products can be found through Defendants publicly distributed brochures, including the exemplar advertisement attached hereto as Exhibit B, as well as on Defendants webpage at http://www.fffenterprises.com/ News/MediaRelease_2013-07-09.aspx. 13. Defendant is thus liable for infringement of the 607 Patent pursuant to 35 U.S.C.

271. Defendant has written notice of its infringement by virtue of the filing and service of this Complaint. 14. As a result of Defendants infringement of the 607 Patent, ABSG has suffered

monetary damages in an amount not yet determined. 15. ABSG will be substantially and irreparably harmed by Defendants infringing

activities unless those activities are enjoined by this Court. ABSG has no adequate remedy at law. As a result of Defendants infringement, ABSG is entitled to preliminary and permanent injunctive relief, restraining and enjoining Defendant and all those in privity with or acting in concert with Defendant from infringing the 607 Patent.ORIGINAL COMPLAINT FOR PATENT INFRINGEMENT PAGE 3

infringement of the 607 Patent; (b) An order for preliminary and permanent injunctive relief prohibiting Defendant, its

officers, agents, servants, employees, successors, assigns, or all other persons or entities in active concert, participation, or privity with any of the foregoing, from any further acts of infringement of the 607 Patent; (c) A judgment and order requiring Defendant to pay ABSG damages under 35 U.S.C.

284, together with pre-judgment and post-judgment interest; (d) and (e) Such other and further relief as the Court deems just and equitable. A judgment and order requiring Defendant to pay ABSG the costs of this action;